Preclinical studies have shown that dual inhibition of PRMT1 and PRMT5 can produce synergistic tumor suppression [122,123], but the broader consequences of disrupting such interactions on normal tissue homeostasis require further investigation. This evidence concerns the gene PRMT5 and neoplasm.